Defective cell cycle checkpoints as targets for anti-cancer therapies
Conventional chemotherapeutics target the proliferating fraction of cells, which will include the tumour cells, but are also toxic to actively proliferating normal tissues. Cellular stresses, such as those imposed by chemotherapeutic drugs, induce cell cycle checkpoint arrest, and recent approaches...
Saved in:
Main Authors: | Brian eGabrielli (Author), Kelly eBrooks (Author), Sandra ePavey (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2012-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cell cycle checkpoint revolution: targeted therapies in the fight against malignant tumors
by: Guangming Song, et al.
Published: (2024) -
Adoptive T cell as a strategy for targeted delivery of immune checkpoint therapy
by: J. Sung, et al.
Published: (2017) -
Targeted Anti-Biofilm Therapy: Dissecting Targets in the Biofilm Life Cycle
by: Fanqiang Bu, et al.
Published: (2022) -
Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer
by: Gian Marco Leone, et al.
Published: (2023) -
Anti‐inflammatory control of human skin keratinocytes by targeting nuclear transport checkpoint
by: Yan Liu, et al.
Published: (2024)